Please assess the completion status of the following clinical trial:

Trial Title: A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* OAB patients who present with OAB symptoms(≥8 micturitions and ≥3 urgency episodes per 24 h documented in the baseline bladder diary)~* OAB patients dissatisfied with their prior therapy with tolterodine~Exclusion Criteria:~* Patients with any contraindication to fesoterodine usage, e.g., urinary retention, gastric retention, uncontrolled narrow-angle glaucoma, or known hypersensitivity to the drug or its ingredients.~* Patients with significant hepatic and renal disease or other significant unstable diseases.~* OAB symptoms caused by neurological conditions, known pathologies of urinary tract, etc.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Open Label-fesoterodine (Type: EXPERIMENTAL): Single treatment study arm.

Based on this trial design, predict the completion outcome and termination type (if applicable).